参考文献/References:
[1] Calpena E, ?López Del Amo V, Chakraborty M, et al. The Drosophila junctophilin gene is functionally equivalent to its four mammalian counterparts and is a modifier of a Huntingtin poly-Q expansion and the Notch pathway[J]. Dis Model Mech.?2018 Jan 17;11(1). pii: dmm029082. doi: 10.1242/dmm.029082.
[2] Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins[J]. Mol Cell,2000,6(1):11-22.
[3] Takeshima H, Hoshijima M, Song LS. Ca2+ microdomains organized by junctophilins[J]. Cell Calcium,2015,58(4):349-356.
[4] Guo A, Wang Y, Chen B, et al. E-C coupling structural protein junctophilin-2 encodes a stress-adaptive transcription regulator[J]. Science,2018,362(6421).?pii: eaan3303. doi: 10.1126/science.aan3303.?
[5] Chu L, Greenstein JL, Winslow RL. Na+ microdomains and sparks: Role in cardiac excitation-contraction coupling and arrhythmias in ankyrin-B deficiency[J]. J Mol Cell Cardiol,2019,128:145-157.
[6] Landstrom AP, Dobrev D, Wehrens X. Calcium signaling and cardiac arrhythmias[J]. Circ Res,2017,120(12):1969-1993.
[7] van Oort RJ, Garbino A, Wang W, et al. Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice[J]. Circulation,2011,123(9):979-988.
[8] Ujihara Y, Mohri S, Katanosaka Y. Effects of induced Na(+)/Ca(2+) exchanger overexpression on the spatial distribution of L-type Ca(2+) channels and junctophilin-2 in pressure-overloaded hearts[J]. Biochem Biophys Res Commun,2016,480(4):564-569.
[9] Guo A, Zhang X, Iyer VR, et al. Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress[J]. Proc Natl Acad Sci U S A,2014,111(33):12240-12245.
[10] Zhang X, Coulibaly ZA, Chen W C, et al. Coupling of SK channels, L-type Ca2+ channels, and ryanodine receptors in cardiomyocytes[J]. Sci Rep,2018,8(1):4670.
[11] Fan HK, Luo TX, Zhao WD, et al. Functional interaction of Junctophilin 2 with small- conductance Ca(2+) -activated potassium channel subtype 2(SK2) in mouse cardiac myocytes[J]. Acta Physiol (Oxf),2018,222(3).doi: 10.1111/apha.12986.
[12] Pinali C, Malik N, Davenport JB, et al. Post-myocardial infarction T-tubules form enlarged branched structures with dysregulation of junctophilin-2 and bridging integrator 1 (BIN-1)[J]. J Am Heart Assoc,2017,6(5).pii: e004834.doi: 10.1161/JAHA.116.004834.
[13] Sabater-Molina M, Navarro M, Garcia-Molina S E, et al. Mutation in JPH2 cause dilated cardiomyopathy[J]. Clin Genet,2016,90(5):468-469.
[14] Vanninen S, Leivo K, Seppala EH, et al. Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure[J]. PLoS One,2018,13(9):e203422.
[15] Reynolds JO, Quick AP, Wang Q, et al. Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca(2+) release[J]. Int J Cardiol,2016,225:371-380.
[16] Guo A, Zhang X, Iyer VR, et al. Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress[J]. Proc Natl Acad Sci U S A,2014,111(33):12240-12245.
[17] Reynolds JO, Chiang DY, Wang W, et al. Junctophilin-2 is necessary for T-tubule maturation during mouse heart development[J]. Cardiovasc Res,2013,100(1):44-53.
[18] Beavers DL, Wang W, Ather S, et al. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization[J]. J Am Coll Cardiol,2013,62(21):2010-2019.
[19] Jiang M, Zhang M, Howren M, et al. JPH-2 interacts with Cai-handling proteins and ion channels in dyads: Contribution to premature ventricular contraction-induced cardiomyopathy[J]. Heart Rhythm,2016,13(3):743-752.
[20] Zhang H B, Li R C, Xu M, et al. Ultrastructural uncoupling between T-tubules and sarcoplasmic reticulum in human heart failure[J]. Cardiovasc Res,2013,98(2):269-276.
[21] 余琳,张进,范洁.心房颤动相关的循环微小RNA[J].心血管病学进展,2018,39(05):795-798.
[22] Quan C, Li M, Du Q, et al. SPEG controls calcium reuptake into the sarcoplasmic reticulum through regulating SERCA2a by its second kinase-domain[J]. Circ Res,2019,124(5):712-726.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(7):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(7):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[4]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[5]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[6]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[7]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(7):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[8]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(7):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[9]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(7):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
[10]李海威 姜红 李宪伦.射血分数保留性心力衰竭患者运动康复的研究进展[J].心血管病学进展,2019,(8):1146.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.019]
LI Haiwei,JIANG Hong,LI Xianlun.Exercise Rehabilitation in Patients with Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(7):1146.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.019]